郭道义

发布者:发布时间:2025-04-17浏览次数:

个人简介

郭道义,男,博士,教授,博士生导师。2015年博士毕业于武汉大学药学院。先后承担国家自然科学基金、江西省杰出青年基金等项目,相关成果申请发明专利10余项(已获授权发明专利 7 项,转让2项),在 Metabolic EngineeringBiotechnology and BioengineeringBioresource TechnologyJournal of Agricultural and Food Chemistry Applied Microbiology and Biotechnology 等期刊上发表 SCI 论文 30余篇。

学术论文情况

[1] C Hu, J Yang, W Guo, H Pan*, D Guo*. De Novo Biosynthesis of 4-Vinylanisole in Engineered Escherichia coli.Journal of Agricultural and Food Chemistry.2024, 72, 8, 4334–4338

[2] H Pan , H Li, S Wu, C Lai ,D Guo*.De Novo Biosynthesis of Anisyl Alcohol and Anisyl Acetate in Engineered. Journal of Agricultural and Food Chemistry. 2023. 71(7) : 3398–3402

[3] D Guo*, S Wu, X Fu, H Pan*. De Novo Biosynthesis of Methyl Cinnamate in Engineered Escherichia coli. Journal of Agricultural and Food Chemistry. 2022, 70, 25, 7736–7741

[4] D Guo*, S Kong, X Chu, X Li, H Pan*. De novo Biosynthesis of Indole-3-acetic acid in Engineered Escherichia coli. Journal of Agricultural and Food Chemistry. 2019,67:8186-8190.

[5] D Guo*, L Zhang, S Kong, Z Liu, X Li, H Pan*. Metabolic engineering of Escherichia coli for production of 2-phenylethanol and 2-phenylethylacetate from glucose. Journal of Agricultural and Food Chemistry. 2018, 66(23):5886-5891.

[6] D Guo, S Kong, L Zhang, H Pan*,C Wang, Z Liu*. Biosynthesis of Advanced Biofuel Farnesyl acetate using engineered Escherichia coli. Bioresource Technology. 2018, 66, 5886-5891

[7] D Guo, J Zhu, Z Deng, T Liu*. Metabolic engineering of Escherichia coli for fatty acid short-chain esters production through the combination of fatty acid and 2-keto acid pathways. Metabolic engineering. 2014(22):69-75.

[8] S Wu, S Kong, C Hu, H Pan*, D Guo*.Metabolic engineering of Escherichia coli for production of acetaminophen from glucose based on high selectivity of N-acetyltransferase.Biochemical Engineering Journal.2024,203,109223

[9] D Guo*, H Pan, X Li*. Metabolic Engineering of Escherichia coli for Production of Biodiesel from Fatty alcohols and Acetyl-CoA. Applied Microbiology and Biotechnology. 2015, 99: 7805-7812.

[10] D Guo*, S Kong,Y Sun, X Li, H Pan*. Development of an artificial biosynthetic pathway for biosynthesis of (S)-reticuline based on HpaBC in engineered Escherichia coli. Biotechnology and Bioengineering. 2021,118:4635–4642.

[11] C Hu, S Wu, H Pan*, D Guo*. De novo Biosynthesis of 2-Phenylacetamide in Engineered Escherichia coli. Biochemical Engineering Journal. 2023,194, 108882.

[12] H Pan, H Li, S Wu, C Lai, D Guo*. De novo biosynthesis of N-acetyltyramine in engineered Escherichia coli, Enzyme and Microbial Technology 2023, 162,110149

[13] Y Sun, S Wu, X Fu, C Lai* and D Guo*. De novo biosynthesis of τcadinol in engineered Escherichia coli. Bioresources and Bioprocessing, 2022, 9:29

[14] D Guo*, X Fu, Y Sun, X Li, H Pan* De novo biosynthesis of tyrosol acetate and

hydroxytyrosol acetate from glucose in engineered Escherichia coli. Enzyme and Microbial Technology 150 (2021) 109886

[15] S Kong, X Fu, X Li, H Pan*, D Guo*. De novo biosynthesis of linalool from glucose in engineered Escherichia coli. Enzyme and Microbial Technology 140 (2020) 109614

[16] H Pan, S Kong, X Fu, X Li, D Guo*. De novo biosynthesis of cinnamyl acetate in

engineered Escherichia coli.Biochemical Engineering Journal 164 (2020) 107796.

[17] Z Liu*, Z Zong, Z Chen, Q Xu, D Li*, H Pan, D Guo*. De novo biosynthesis of

antimycobacterial agent geranylgeranyl acetate from glucose. Biochemical Engineering Journal, 2019,142:84-88

[18] S Kong, H Pan, X Liu, X Li, D Guo*. De novo biosynthesis of 2-phenylethanol in engineered Pichia pastoris. Enzyme and Microbial Technology. 2020 (133) 109459.

[19] S Kong, J Zhang, X Li, H Pan*, D Guo*. De novo biosynthesis of indole-3-ethanol and indole-3-ethanol acetate in engineered Escherichia coli. Biochemical Engineering Journal.2020 (154) 107432.

[20] H Pan, L Zhang, X Li, D Guo*. Biosynthesis of the fatty acid isopropyl esters by engineered Escherichia coli. Enzyme and Microbial Technology. 2017, 102: 49-52

[21] D Guo*, L Zhang, H Pan, X Li*. Metabolic engineering of Escherichia coli for production of 2-Phenylethylacetate from L-phenylalanine. MicrobiologyOpen. 2017, 6: e486

[22] D Guo*, X Fu, S Kong, X Li, H Pan*. Biosynthesis of actarit using engineered Escherichia coli. Enzyme and Microbial Technology 150 (2021) 109858

[23] L Zhang, Q Liu, H Pan*, Xun Li, D Guo*. Metabolic engineering of Escherichia coli to high

efficient synthesis phenylacetic acid from phenylalanine. AMB Express. 20177:105.

[24] .D Guo, H Pan, D Zeng, Y Li , X Li, X Fan*. Inactivating Hemocyanin from OncomelaniaHupensis With 4-(chloroacetyl)catechol and Its Application in Snail Control. Pesticide Biochemistry and Physiology. 2012, (103):233–236.

[25] D Guo, H Wang, D Zeng, X Li, X Fan*, Y Li*.Vaccine potential of hemocyanin from Oncomelania hupensis against Schistosoma Japonicum. Parasitology International. 2011(60):242–246.

[26] D Guo, Y Zhang, D Zeng, H Wang, X Li, Y Li, X Fan*. Functional Properties of Hemocyanin from Oncomelania Hupensis, the Intermediate Host of Schistosoma Japonicum. Experimental Parasitology. 2009(123):277-281.